EosGene Therapeutics

EosGene Therapeutics: Pioneering Gene Therapy for a Brighter Future EosGene Tx is dedicated to address a significant healthcare challenge of diabetic retinopathy by harnessing the power of CRISPR-based gene therapy. With our ground-breaking liposome delivery technology, we're at the forefront of transforming treatment possibilities. Our approach employs the revolutionary CRISPR editing tool to precisely target the disease-associated gene, paving the way for therapeutic breakthroughs. To ensure both effectiveness and safety of the therapy, we've developed an innovative liposome delivery technology that achieves the spatial-temporal release of CRISPR agents to the affected retinal cells. Our objective is clear: to halt or even reverse the progression of diabetic retinopathy by correcting genetic mutations and dysfunctions at their source. Guided by world-class scientists and business leaders, our team brings a wealth of experience and expertise in the dynamic realm of biotechnology.